Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription 06.08.2018 3 Antimicrob Agents Chemother 1 Clin Infect Dis 1 J Immunol 1 J Infect Dis 6 Lancet Infect Dis 1 N Engl J Med 6 PLoS One 1 Trop Med Int Health

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. DOOKIE N, Naidoo K, Padayatchi N
   Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
   Antimicrob Agents Chemother. 2018;62.
   PubMed     Text format    
   
   
2. KOSER CU, Heyckendorf J, Andres S, Olaru ID, et al
   Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
   Antimicrob Agents Chemother. 2018;62.
   PubMed     Text format    
   
   
3. JAGIELSKI T, Bakula Z, Brzostek A, Minias A, et al
   Characterization of mutations conferring resistance to rifampicin in Mycobacterium tuberculosis clinical strains.
   Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.01093.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

4. NGWIRA LG, Corbett EL, Khundi M, Barnes GL, et al
   Screening for tuberculosis with Xpert MTB/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA).
   Clin Infect Dis. 2018 Jul 27. pii: 5060257. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

5. OLIVE AJ, Smith CM, Kiritsy MC, Sassetti CM, et al
   The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection.
   J Immunol. 2018 Jul 30. pii: jimmunol.1800202. doi: 10.4049/jimmunol.1800202.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

6. CANADAY DH, Toossi Z
   Granulomatous responses in HIV/TB co-infection.
   J Infect Dis. 2016.
   PubMed     Text format    
   
   

   
   Lancet Infect Dis

7. SASSALOS TM, Rao RC, Demirci H
   Ocular tuberculosis masquerading as a tumor.
   Lancet Infect Dis. 2018;18:924.
   PubMed     Text format    
   
   
8. SCHRAGER LK, Chandrasekaran P, Fritzell BH, Hatherill M, et al
   WHO preferred product characteristics for new vaccines against tuberculosis.
   Lancet Infect Dis. 2018;18:828-829.
   PubMed     Text format    
   
   
9. MENZIES NA, Cohen T, Salomon JA
   Evidence sources on the natural history of latent tuberculosis infection.
   Lancet Infect Dis. 2018;18:834-835.
   PubMed     Text format    
   
   
10. ANDRE E
    Prevalence of drug-resistant tuberculosis in South Africa.
    Lancet Infect Dis. 2018;18:835-836.
    PubMed     Text format    
    
    
11. MAHLA RS
    Prevalence of drug-resistant tuberculosis in South Africa.
    Lancet Infect Dis. 2018;18:836.
    PubMed     Text format    
    
    
12. ISMAIL NA, Omar SV, Mvusi L, Madhi SA, et al
    Prevalence of drug-resistant tuberculosis in South Africa - Authors' reply.
    Lancet Infect Dis. 2018;18:836-837.
    PubMed     Text format    
    
    

    
    N Engl J Med

13. MENZIES D, Adjobimey M, Ruslami R, Trajman A, et al
    Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
    N Engl J Med. 2018;379:440-453.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

14. NGUYEN DT, Jenkins HE, Graviss EA
    Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
    PLoS One. 2018;13:e0196022.
    PubMed     Text format     Abstract available
    
    
15. LOVEDAY M, Wallengren K, Reddy T, Besada D, et al
    MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    PLoS One. 2018;13:e0196003.
    PubMed     Text format     Abstract available
    
    
16. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    PubMed     Text format     Abstract available
    
    
17. DUTTA A, Pattanaik S, Choudhury R, Nanda P, et al
    Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India.
    PLoS One. 2018;13:e0196067.
    PubMed     Text format     Abstract available
    
    
18. CHIHOTA VN, Niehaus A, Streicher EM, Wang X, et al
    Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
    PLoS One. 2018;13:e0200632.
    PubMed     Text format     Abstract available
    
    
19. MUTTAMBA W, Ssengooba W, Sekibira R, Kirenga B, et al
    Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    PLoS One. 2018;13:e0194741.
    PubMed     Text format     Abstract available
    
    

    
    Trop Med Int Health

20. HAYASHI S, Chandramohan D
    Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis.
    Trop Med Int Health. 2018 Jul 30. doi: 10.1111/tmi.13133.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: